DevicePMAs@therightstef:P010029_S000 11 Projects
|
Approval for nuflexxa (1% sodium hyaluronate). The device is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e. g., acetaminophen).
|
Annnotations
- Denotations: 0
- Blocks: 0
- Relations: 0